Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Drug Discovery
179 Articles Available
1
8
Can't find what you're looking for? Try our
advanced search
.
In Vitro Biology
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
PR-M10-23-04
3D Cell Culture
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
PAO-09-23-CL-02
R&D
Integrating Digital Solutions to Streamline Biopharma Operations
PAO-07-23-CL-06
Oncology
Addressing Cancer Therapy Resistance by Targeting Translational Regulation
PAO-06-23-CL-02
Generative AI
Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat
PAO-04-23-CL-02
Targeted Protein Degradation
Targeted Protein Degradation Provides Promising Alternative to Address Unmet Medical Needs
PAO-03-23-CL-07
Tumor Microenvironment
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
PAO-03-23-CL-01
Digital Twin Technology
The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More
PAO-03-23-NI-02
Therapeutic Candidate
CytoDyn Takes Steps towards a Brighter Future
PAO-02-23-CL-04
Artificial Intelligence
Artificial Intelligence in Pharma, As Told by Artificial Intelligence
PAO-01-23-CL-02
Artificial Intelligence in Antibody Design
Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence
PAO-11-022-CL-15
Three Benefits of Using In Silico Technologies for Drug Discovery
Synthetic Biology
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
PAO-12-022-NI-01
Computational Drug Design
Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery
PAO-11-022-CL-11
Big Data
Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More
PAO-10-022-NI-05
Transient Expression
Overcoming Limitations with Transient Protein Expression to Accelerate Development
PAO-10-022-CL-02
Drug Discovery
Enabling Seamless Workflows for Small Molecule Drug Discovery
PAO-08-022-CL-08
R&D Data Management
Dotmatics Launches Small Molecule Drug Discovery Solution Helping Researchers Accelerate Life-Improving Therapies
PR-M07-22-05
Quantum Computing
Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management
PAO-06-022--NI-10
Enabling Drug Discovery Targeting Ion Channels
Ion Channels
Ophthalmic
Transformative Early and Patient-Centric Treatments for Retinal Diseases
PAO-05-022-CL-06
mRNA
The Intersection of mRNA Biology and Artificial Intelligence is Yielding Unique mRNA Drug Candidates
PAO-04-022-CL-14
Oncology
Fighting Cancer and Supporting Patients
PAO-04-22-R250-13
New Drug Development
Venomtech Announces New Drug Development Collaboration with Charles River
PR-M04-22-06
1
8
»